Li Y - Search Results

1

Immunotherapy: Review of the Existing Evidence and Challenges in Breast Cancer.

Hu Y, Li Y, Yao Z, Huang F, Cai H, Liu H, Zhang X, Zhang J. Hu Y, et al. Among authors: li y. Cancers (Basel). 2023 Jan 17;15(3):563. doi: 10.3390/cancers15030563. Cancers (Basel). 2023. PMID: 36765522 Free PMC article. Review.

2

Targeting CDK1 and copper homeostasis in breast cancer via a nanopolymer drug delivery system.

Shang N, Zhu L, Li Y, Song C, Liu X. Shang N, et al. Among authors: li y. Cell Biol Toxicol. 2024 Dec 26;41(1):16. doi: 10.1007/s10565-024-09958-2. Cell Biol Toxicol. 2024. PMID: 39724454 Free PMC article.

3

Models for Predicting Response to Immunotherapy and Prognosis in Patients with Gastric Cancer: DNA Damage Response Genes.

Dong R, Chen S, Lu F, Zheng N, Peng G, Li Y, Yang P, Wen H, Qiu Q, Wang Y, Wu H, Liu M. Dong R, et al. Among authors: li y. Biomed Res Int. 2022 Dec 19;2022:4909544. doi: 10.1155/2022/4909544. eCollection 2022. Biomed Res Int. 2022. PMID: 36578802 Free PMC article.

4

How neutrophils shape the immune response of triple-negative breast cancer: Novel therapeutic strategies targeting neutrophil extracellular traps.

Liang B, Yuan Y, Jiang Q, Ma T, Liu X, Li Y. Liang B, et al. Among authors: li y. Biomed Pharmacother. 2024 Sep;178:117211. doi: 10.1016/j.biopha.2024.117211. Epub 2024 Jul 27. Biomed Pharmacother. 2024. PMID: 39068851 Free article. Review.

5

Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models.

Guo Z, Li Y, Zhang D, Ma J. Guo Z, et al. Among authors: li y. Oncotarget. 2017 Sep 21;8(52):89761-89774. doi: 10.18632/oncotarget.21125. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163786 Free PMC article.

6

Engineering macrophages and their derivatives: A new hope for antitumor therapy.

Wei F, Liu H, Wang Y, Li Y, Han S. Wei F, et al. Among authors: li y. Biomed Pharmacother. 2024 Aug;177:116925. doi: 10.1016/j.biopha.2024.116925. Epub 2024 Jun 14. Biomed Pharmacother. 2024. PMID: 38878637 Free article. Review.

7

Tumour targetable and microenvironment-responsive nanoparticles simultaneously disrupt the PD-1/PD-L1 pathway and MAPK/ERK/JNK pathway for efficient treatment of colorectal cancer.

Li Y, Qi M, Ding F, Lv Y, Ma J, Zhu Y. Li Y, et al. J Drug Target. 2021 Apr;29(4):454-465. doi: 10.1080/1061186X.2020.1853750. Epub 2020 Dec 3. J Drug Target. 2021. PMID: 33233956

8

Sarcopenia and interleukin-23 in colorectal cancer survival.

Gao S, Li Y. Gao S, et al. Among authors: li y. Clin Nutr. 2022 Jan;41(1):9-10. doi: 10.1016/j.clnu.2021.11.015. Epub 2021 Nov 23. Clin Nutr. 2022. PMID: 34861625 No abstract available.

9

Retraction Note: MEK inhibitors induce apoptosis via FoxO3a-dependent PUMA induction in colorectal cancer cells.

Lin L, Ding D, Jiang Y, Li Y, Li S. Lin L, et al. Among authors: li s, li y. Oncogenesis. 2024 Nov 21;13(1):41. doi: 10.1038/s41389-024-00543-0. Oncogenesis. 2024. PMID: 39572524 Free PMC article. No abstract available.

10

GRP75 Modulates Endoplasmic Reticulum-Mitochondria Coupling and Accelerates Ca²⁺-Dependent Endothelial Cell Apoptosis in Diabetic Retinopathy.

Li Y, Li HY, Shao J, Zhu L, Xie TH, Cai J, Wang W, Cai MX, Wang ZL, Yao Y, Wei TT. Li Y, et al. Among authors: li hy. Biomolecules. 2022 Nov 29;12(12):1778. doi: 10.3390/biom12121778. Biomolecules. 2022. PMID: 36551205 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240,872 results

Search Page

Filters